Brinker Capital Investments, LLC Reata Pharmaceuticals Inc Transaction History

Brinker Capital Investments, LLC

  • $10.5 Billion
  • Q2 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Jul 31, 2025
SELL
$0.0 - $172.36 $0 - $462,269
-2,682 Closed
0 $0
Q2 2023

Jul 31, 2025
BUY
$79.22 - $105.37 $396 - $526
5 Added 0.19%
2,682 $273,000
Q1 2023

Jul 31, 2025
BUY
$30.85 - $93.17 $82,585 - $249,416
2,677 New
2,677 $243,000

Others Institutions Holding RETA

# of Institutions
5
Shares Held
62.7K
Call Options Held
0
Put Options Held
0
View Full List

About REATA PHARMACEUTICALS INC

RETA Quotes by TradingView
  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track Brinker Capital Investments, LLC Portfolio

Follow Brinker Capital Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brinker Capital Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brinker Capital Investments, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email